Sinus MRSA: What to do when Methicillin Resistant Staph Aureus Infects Your Patient
MRSA the "Superbug" is in the news and is more prevalent than ever before. MRSA can also invade the sinuses and cause tough sinus infections, which are difficult to treat. This article discuses treatment options for patients with serious MRSA staph infections in the sinuses and offers solutions to physicians for erradicating these organisms.
New Study Shows Condoms 95 Times More Cost-Effective than Circumcision in HIV Battle
Results of the new study, ?The Cost to Circumcise Africa,? comparing the cost of male circumcision to the cost of lifetime distribution of free condoms in sub-Saharan Africa, found that condom distribution is 95 times more cost-effective in preventing the same number of infections in Sub-Saharan Africa.
Facial Fillers Now Allow HIV-positive and AIDS Patients to Avoid Social Stigma
Dr. Scott W. Mosser, a San Francisco Board-Certified Plastic Surgeon reflects on options for facial fillers to treat HIV+ associated facial lipoatrophy (facial wasting). Dr. Mosser focuses on Sculptra, the only product approved by the US Food and Drug Administration to treat HIV-associated facial wasting.
Mobility Matters for Polio-disabled of Sierra Leone
Mercy Ships highlights contributions of West African polio communities on World Polio Day
New Potent Nanoassemblies to Fight Cancer and HIV
Nucleoside analogues, which are a class of therapeutic agents, display significant anticancer or antiviral activity by interfering with DNA synthesis. They work by incorporating into the elongating DNA strands and terminating the extension process. However, they also affect normal cell growth, such as bone marrow cells, so there can be significant toxic effects. Further limitations to their use are relatively poor intracellular diffusion, rapid metabolism, poor absorption after oral use, and the induction of resistance. French and Italian researchers have now come up with a completely new approach to render anticancer and antiviral nucleoside analogues significantly more potent. By linking the nucleoside analogues to squalene, a biochemical...
Launch of microbicide expected to AID in the prevention of STD'S and HIV
LA JOLLA, CA (March 24, 2008)- Today, Instead Sciences, Inc. announced that its microbicidal personal lubricant, Amphora, which has been cleared as safe for human use by the FDA, has shown promising results in clinical studies to also prevent the contraction of certain sexually transmitted diseases, including HSV (Herpes), gonorrhea, Chlamydia, and HIV. In light of the revealing report published earlier this month by the Centers for Disease Control (CDC) stating that one in four teenagers has a sexually transmitted infection, the announcement of a microbicide which may prevent the spread of these diseases is very encouraging.
Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection : Healthcare Facility Infection Prevention and Control Pro
More than three out of four (76%) infection prevention and control professionals (ICPs) polled indicated they have implemented additional measures to prevent the transmission of methicillin-resistant Staphylococcus aureus (MRSA) in the last year, but 54% said their institutions are not doing as much as they could and should be doing to prevent the spread of this virulent pathogen, according to an online survey conducted by the Association for Professionals in Infection Control and Epidemiology (APIC).
Other Sites of Interest
Check out these other sites of interest in our network of sites.
|
